Community Pharmacists and Opioid Misuse

NACompletedINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

September 15, 2017

Primary Completion Date

March 27, 2019

Study Completion Date

June 1, 2019

Conditions
Opioid Misuse
Interventions
BEHAVIORAL

Brief Intervention Medication Therapy Management

BI-MTM is designed to: (1) eliminate opioid medication misuse, (2) promote opioid regimen adherence, (3) connect participants with Patient Navigation to increase patient self-management activation for health conditions that increase risk for misuse (Patient Navigation is an evidence-based chronic care intervention), and (4) provide naloxone rescue training referrals.

BEHAVIORAL

Standard Medication Counseling (SMC)

Standard Medication Counseling (SMC; n=23; i.e., treatment-as-usual condition). Standard Medication Counseling is the Centers for Medicaid and Medicare Services requirement for pharmacists in the US wherein pharmacy patients filling prescriptions receive information and opt-in counseling.

Trial Locations (2)

15213

Falk Pharmacy, Pittsburgh

15501

Medicine Shoppe, Somerset

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

University of Utah

OTHER

NCT03149718 - Community Pharmacists and Opioid Misuse | Biotech Hunter | Biotech Hunter